Safety of the oxaliplatin readministration by the desensitization for metastatic colorectal cancer patients having oxaliplatin allergy

ABSTRACT: Interventions: desensitization Primary outcome(s): the rate of oxaliplatin readministration without allergy Study Design: Single arm Non-randomized

DISEASE(S): Colorectal Carcinoma

PROVIDER: 2625519 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR